Transcription of Full Prescribing Information - NERLYNX
{{id}} {{{paragraph}}}
Example: air traffic controller
Full Prescribing Information - NERLYNX
HIGHLIGHTS OF Prescribing Information These highlights do not include all the Information needed to use NERLYNX safely and effectively. See full Prescribing Information for NERLYNX . NERLYNX (neratinib) tablets, for oral use Initial Approval: 2017 _____ INDICATIONS AND USAGE _____ NERLYNX is a kinase inhibitor indicated for the extended adjuvant treatment of adult patients with early stage HER2-overexpressed/amplified breast cancer, to follow adjuvant trastuzumab-based therapy. (1, 14) _____ DOSAGE AND ADMINISTRATION _____ Antidiarrheal prophylaxis: Initiate loperamide with the first dose of NERLYNX and continue during first 2 cycles (56 days) of treatment.
2.3 Dose Modifications Dose Modifications for Adverse Reactions NERLYNX dose modification is recommended based on individual safety and tolerability.
Loading..
Tags:
Information
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document:
Related search queries
Safety, Pfizer, Reports, Efavirenz Safety Review, Assessment of Periodic, Assessment of periodic safety, Guideline E2F on development safety update, E2F – Development SafetyDevelopment Safety Update Report, Development safety update report, Manual tasks audit guide, Manual tasks audit – guide, Health, World Health Organization